Expert questions NICE advice on PSA testing
By Nigel Praities
A leading NICE advisor has cast doubt on the institute's recommendation that PSA testing should be used for diagnosis of prostate cancer, warning it placed GPs under pressure with little evidence of benefit.
Speaking at Primary Care 2008 in Birmingham, Professor David Weller, head of general practice at the University of Edinburgh and a key advisor to NICE, also said many GPs now faced requests for PSA testing on almost a daily basis – but warned there was scant evidence they reduced mortality. ‘The dilemma with PSA testing is you end up doing a lot of tests and treatment, but mortality rates remain low.'